Postoperative pathology and genetic examination confirmed the diagnosis of glioblastoma [World Health Organization (WHO) stage IV] (Figure 1D), with an IDH wild-type genotype and a positive methylation status of the MGMT promoter. The gene discussed is MGMT; the disease is glioblastoma.